Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY)

Market Cap	8.41B +0.0%
Revenue (ttm)	41.77B +4.4%
Net Income	842.24M +33.8%
EPS	0.23 +33.6%
Shares Out	n/a
PE Ratio	9.98
Forward PE	14.53
Dividend	0.20 (2.64%)
Ex-Dividend Date	Dec 31, 2025

Volume	400
Average Volume	590
Open	7.60
Previous Close	7.60
Day's Range	7.60 - 7.60
52-Week Range	6.39 - 8.32
Beta	0.25
RSI	48.74
Earnings Date	Apr 29, 2026

About SHPMY

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,608
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHPMY

Financial Performance

In 2025, SHPMY's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY